Bio-Rad Laboratories, Inc. (BUWA.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 08:20AM CEST. Market open.
| Previous Close | 259.50 |
| Open | 248.50 |
| Bid | 248.50 x 5000 |
| Ask | 250.90 x 5000 |
| Day's Range | 248.50 - 248.50 |
| 52 Week Range | 248.50 - 383.80 |
| Volume | |
| Avg. Volume | 8 |
| Market Cap | 6.868B |
| Beta (5Y Monthly) | 0.94 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -9.94 |
| Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 856.25 |
ZacksBio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down
Bio-Rad's (BIO) Clinical Diagnostics arm registers growth in Q1, primarily driven by an increased demand for quality control, blood typing, and diabetes products.
Insider MonkeyBio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript May 7, 2024 Bio-Rad Laboratories, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon everyone, and welcome to today’s Bio-Rad First Quarter 2024 Earnings Results Conference Call. At this […]
- Thomson Reuters StreetEvents
Q1 2024 Bio Rad Laboratories Inc Earnings Call
Q1 2024 Bio Rad Laboratories Inc Earnings Call
© 2024 Yahoo. All rights reserved.